The FDA approved ocrelizumab and hyaluronidase-ocsq (Ocrevus Zunovo; Genentech), a twice-yearly subcutaneous injection, for relapsing multiple sclerosis (RMS) and primary progressive multiple ...
What is the current share price of Ramelius Resources Limited (RMS)? Ramelius Resources Limited's (RMS) current share price is $2.27. This constitutes a price movement of 4.13% when compared to the ...